TMC Life Sciences Berhad (KLSE:TMCLIFE)

TMC Life Sciences Berhad Revenue

In the fiscal year ending June 30, 2026, TMC Life Sciences Berhad had annual revenue of 393.03M MYR with 13.71% growth. TMC Life Sciences Berhad had revenue of 99.35M in the quarter ending June 30, 2026, with 6.41% growth.

• Revenue: 393.03M
• Revenue Growth: +13.71%
• P/S Ratio: 1.97
• Revenue / Employee: n/a
• Employees: n/a
• Market Cap: 775.14M

Revenue Chart

Chart

Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Jun 30, 2026	393.03M	47.39M	13.71%
Jun 30, 2025	345.63M	-784.00K	-0.23%
Jun 30, 2024	346.42M	34.86M	11.19%
Jun 30, 2023	311.56M	67.78M	27.81%
Jun 30, 2022	243.77M	42.75M	21.27%

Data Source: S&P Global Market Intelligence Last updated: Jun 30, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Aug 29, 2026

Data Sources Report a data error